We are live on ! Find out more
TROVW

TrovaGene, Inc. Warrant
TROVW

Delisted

TROVW was delisted on the 30th of May, 2017.

Back to rankings

3 hedge funds and large institutions have $272K invested in TrovaGene, Inc. Warrant in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% less funds holding

Funds holding: 4 → 3 (-1)

59% less capital invested

Capital invested by funds: $656K → $272K (-$384K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $10K

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
$10K
Net Calls
-$10K
Net Calls Change
+$9K

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$1.91K
2
UBS Group
UBS Group
Switzerland
-$82
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$269K – – –
Morgan Stanley
2
Morgan Stanley
New York
$3K -$1.91K -2,322 -22%
UBS Group
3
UBS Group
Switzerland
– -$82 -100 -85%

TROVW Hedge Fund Activity: Q4 2016 in Review

3 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q4 2016, worth a combined $272K — down 59% from $656K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of TROVW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, cutting an estimated $1.91K.

  • 3 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q4 2016, down from 4 in Q3 2016.
  • Funds reported $272K of TrovaGene, Inc. Warrant stock for Q4 2016, down 59% quarter-over-quarter.
  • 0 funds opened new TrovaGene, Inc. Warrant positions in Q4 2016 and 1 closed out, a net change of -1 holder.
  • The largest TrovaGene, Inc. Warrant seller in Q4 2016 was Morgan Stanley, an estimated $1.91K sold.

Based on aggregated 13F filings for Q4 2016.